Gastric & Breast Cancer e-journal
DOI: 10.2122/gbc.2018.0270
News & Views
|
Pancreatic cancer genome analysis. New predictive approaches.
|
Evangelos Felekouras, MD, PhD.
|
Affiliation:1st Department of Surgery, Laikon General Hospital, National and Kapodistrian University of Athens, Athens, Greece. Rolex Replica Watches
Tel:+30213-206-1283
F: +30213-206-1779
E-mail: felek@med.uoa.gr |
Abstract
Pancreatic adenocarcinoma is one of the most aggressive tumors with high mortality rates even in early-stage after surgical resection and adjuvant treatment.
Next-generation sequencing (NGS) in patient-derived samples has led into recent reports providing exciting data on pancreatic cancer driver genes druggable mutations.
Whether the shifting from current progress to advances for the development of prognostic and predictive biomarkers with genome sequencing is discussed in this article.
(Citation: Gastric & Breast Cancer 2018; 13(1): 8-14)
|
|
| You can have an online full-text access and a PDF of this article: |
- Either purchase this paper for €35 EUR. Please, click here
|
|
- Or through one year subscription PayPal
|
|
